scispace - formally typeset
G

Gereon R. Fink

Researcher at Forschungszentrum Jülich

Publications -  976
Citations -  67974

Gereon R. Fink is an academic researcher from Forschungszentrum Jülich. The author has contributed to research in topics: Medicine & Functional magnetic resonance imaging. The author has an hindex of 114, co-authored 867 publications receiving 60853 citations. Previous affiliations of Gereon R. Fink include University of Geneva & University of Hamburg.

Papers
More filters
Journal ArticleDOI

Self-awareness: the neural signature of disturbed self-monitoring.

Gereon R. Fink
- 17 Nov 2014 - 
TL;DR: A new study reveals that the illusion of feeling another person close by results from a misperception of the source and identity of sensorimotor signals of one's own body.
Book ChapterDOI

Positron Emission Tomography Activation Studies in Neurological Patients

TL;DR: This report describes the experience of a few cognitive and behavioral activation paradigms in various common neurological diseases using positron emission tomography in brain regions showing no gross structrual abnormality.
Journal ArticleDOI

Hand preference for the visual and auditory modalities in humans.

TL;DR: In this article, the authors applied the adapted Colavita paradigm and recruited a large cohort of healthy right-handed participants (n = 119) to investigate how the sensory dominance effect interacts with hand dominance, and found that half of the right-handers exhibited a visual preference, i.e., their dominant hand effect manifested in responding to the visual stimuli.
Journal ArticleDOI

Severe occipital neck pain and a deviating tongue

TL;DR: A 46-year-old woman presented with a 3-month history of severe cervico-occipital pain and on repeated examination, it was noted that her tongue deviated to the left and that it was partly atrophic, diagnostic of left hypoglossal nerve palsy.
Journal ArticleDOI

Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes.

TL;DR: In this article , a prospective, observational, international multicentre study with a 6-month follow-up, assessed the Non-Motor Symptom Scale (NMSS) as primary and the following secondary outcomes: Unified PD Rating Scale-motor examination (UPDRS-III), Scales for Outcomes in PD (SCOPA)-activities of daily living (ADL) and -motor complications, PDQuestionnaire-8 (PDQ-8), and levodopa-equivalent daily dose (LEDD).